Primary infection foci | Skin and other soft tissue infection (n = 30) | Infective endocarditis (n = 20) | Liver abscess (n = 17) | Catheter-associated blood stream infection (n = 9) | Urinary tract infection (n = 6) | Perianal abscess (n = 5) | Other infection And unknown (n = 11) |
---|---|---|---|---|---|---|---|
 Age, years§ | 49.1 ± 17.0 | 38.8 ± 14.2 | 46.8 ± 13.3 | 52.2 ± 14.3 | 51.0 ± 8.0 | 52.5 ± 10.4 | 46.2 ± 18.0 |
 Pathogens* | |||||||
 Gram-positive | 16 | 8 | 2 | 2 | 1 | 0 | 1 |
 Gram-negative | 14 | 2 | 12 | 3 | 4 | 2 | 1 |
 Fungus | 6 | 2 | 1 | 3 | 5 | 0 | 0 |
 MDRP** | 11 | 2 | 6 | 4 | 0 | 2 | 0 |
Predisposing conditions | Â | ||||||
 Diabetes mellitus** | 14 | 8 | 9 | 3 | 3 | 1 | 3 |
 Nosocomial infection | 7 | 3 | 3 | 4 | 2 | 1 | 1 |
 IV drug use | 4 | 6 | 3 | 2 | 1 | 2 | 0 |
 Immunosuppressed state | 5 | 3 | 3 | 2 | 2 |  | 1 |
 Injury or other trauma | 4 | 2 | 2 | 1 | 1 | 1 | 1 |
 Antimicrobial therapy | |||||||
 Cephalosporin | 17 | 10 | 7 | 2 | 1 | 2 | 4 |
 Vancomycin | 19 | 11 | 0 | 6 | 1 | 0 | 2 |
 Carbapenem | 6 | 5 | 4 | 4 | 1 | 1 | 2 |
 Piperacillin-tazobactam | 4 | 4 | 6 | 1 | 2 | 1 | 2 |
 Aminoglycosides | 0 | 0 | 10 | 1 | 4 | 4 | 0 |
 Quinolones | 2 | 2 | 2 | 0 | 4 | 0 | 2 |
 Antifungal therapy | 8 | 4 | 2 | 4 | 5 | 0 | 3 |
 Drainage | 7 |  | 14 | 1 | 2 | 2 | 0 |
 Death | 6 | 4 | 3 | 3 | 1 | 1 | 1 |
 Duration of hospitalization, days§ | 23.4 ± 12.1 | 19.9 ± 9.4 | 22.3 ± 9.4 | 24.1 ± 16.2 | 17.3 ± 6.4 | 32.1 ± 11.0 | 20.8 ± 6.0 |